Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
From Evidence to Practice: Denosumab in Osteoporosis and Joint Health
View through CrossRef
Osteoporosis and osteopenia are prevalent conditions in India, particularly among postmenopausal women and the elderly, leading to increased fracture risks and morbidity. Denosumab, a monoclonal antibody, demonstrates superior efficacy over other treatments in reducing fracture risk and enhancing bone mineral density (BMD). Clinical trials highlight its effectiveness in preventing periprosthetic bone loss, improving implant stability, and mitigating femoral head collapse in various conditions; combination therapies involving denosumab further amplify BMD gains and reduce fracture risk. The article reviews the efficacy and safety of denosumab in managing osteoporosis, joint replacement therapy, and avascular necrosis based on a review of clinical evidence and studies. Denosumab emerges as a cornerstone therapy for osteoporosis management, offering multifaceted benefits in fracture prevention, joint replacement therapy, and avascular necrosis.
Indian Journal of Clinical Practices Publications LTD
Title: From Evidence to Practice: Denosumab in Osteoporosis and Joint Health
Description:
Osteoporosis and osteopenia are prevalent conditions in India, particularly among postmenopausal women and the elderly, leading to increased fracture risks and morbidity.
Denosumab, a monoclonal antibody, demonstrates superior efficacy over other treatments in reducing fracture risk and enhancing bone mineral density (BMD).
Clinical trials highlight its effectiveness in preventing periprosthetic bone loss, improving implant stability, and mitigating femoral head collapse in various conditions; combination therapies involving denosumab further amplify BMD gains and reduce fracture risk.
The article reviews the efficacy and safety of denosumab in managing osteoporosis, joint replacement therapy, and avascular necrosis based on a review of clinical evidence and studies.
Denosumab emerges as a cornerstone therapy for osteoporosis management, offering multifaceted benefits in fracture prevention, joint replacement therapy, and avascular necrosis.
Related Results
Underweight Sebagai Faktor Resiko Osteoporosis Pada Lansia
Underweight Sebagai Faktor Resiko Osteoporosis Pada Lansia
Osteoporosis is a bone disease characterized by decreased bone density. The incidence of osteoporosis increases with age, especially age ≥ 50 years. Research from the International...
pdf Nestatin-1 Level as Potential Parameters in T2DM with and Without Osteoporosis
pdf Nestatin-1 Level as Potential Parameters in T2DM with and Without Osteoporosis
In osteoporosis (OP) disease, the strength of bones is decreased, and it is mostly correlated with the loss of bone tissues and destruction of bone micro structure, making the pati...
The Role of Denosumab and Bisphosphonate in Osteogenesis Imperfecta: A Literature Review
The Role of Denosumab and Bisphosphonate in Osteogenesis Imperfecta: A Literature Review
Osteogenesis Imperfecta (OI) is a rare genetic disorder characterized by brittle bones and susceptibility to fractures. Management of OI focuses on minimizing fractures and improvi...
From Evidence to Practice: Denosumab in Osteoporosis and Joint Health
From Evidence to Practice: Denosumab in Osteoporosis and Joint Health
Osteoporosis and osteopenia are prevalent conditions in India, particularly among postmenopausal women and the elderly,leading to increased fracture risks and morbidity. Denosumab,...
Sistem Pakar Untuk Penentuan Terapi Pada Penderita Osteoporosis
Sistem Pakar Untuk Penentuan Terapi Pada Penderita Osteoporosis
Abstract - Osteoporosis is a disease caused by loss of bone mass, especially lack of calcium. Treatment of osteoporosis can be done by doing osteoporosis therapy. In the expert sys...
P05 Osteoporosis in thalassemia; a case with multifactorial aetiology
P05 Osteoporosis in thalassemia; a case with multifactorial aetiology
Abstract
Introduction
Thalassemia patients are prone to osteoporosis due to multifactorial reasons, including anaemia, bone marr...
Closing the osteoporosis care gap – Increased osteoporosis awareness among geriatrics and rehabilitation teams
Closing the osteoporosis care gap – Increased osteoporosis awareness among geriatrics and rehabilitation teams
Abstract
Background
A care gap exists between recommendations and practice regarding the diagnosis and treatment of osteoporosis in fracture pati...
A pooled analysis of the association between sarcopenia and osteoporosis
A pooled analysis of the association between sarcopenia and osteoporosis
Background:
Sarcopenia is a progressive generalized skeletal muscle disorder that causes the accelerated loss of muscle mass and function. Osteoporosis is a systemic co...